Safety and Immunogenicity of an Anti–Zika Virus DNA Vaccine

There are no known specific therapies or vaccines to treat or prevent Zika virus infection. In this report, encouraging data are presented from a phase 1 study of a DNA vaccine against ZIKV infection.

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The New England journal of medicine Jg. 385; H. 12; S. e35
Hauptverfasser:	Tebas, Pablo, Roberts, Christine C, Muthumani, Kar, Reuschel, Emma L, Kudchodkar, Sagar B, Zaidi, Faraz I, White, Scott, Khan, Amir S, Racine, Trina, Choi, Hyeree, Boyer, Jean, Park, Young K, Trottier, Sylvie, Remigio, Celine, Krieger, Diane, Spruill, Susan E, Bagarazzi, Mark, Kobinger, Gary P, Weiner, David B, Maslow, Joel N
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	United States Massachusetts Medical Society 16.09.2021
Schlagworte:	Adult Adverse events Animals Antibodies Antibodies, Neutralizing - blood Antibodies, Viral - blood Clinical trials Confidence intervals Congenital defects Dengue fever Deoxyribonucleic acid DNA DNA vaccines DNA viruses Electroporation Enzyme-linked immunosorbent assay Enzymes FDA approval Female Global Health Guillain-Barre syndrome Humans Immune response Immunization Immunogenicity Immunogenicity, Vaccine Infections Infectious Disease Injection Injections, Intradermal - adverse effects Laboratories Lethal dose Life sciences Male Mice Mice, Knockout Middle Aged Nucleotide sequence Peptides Safety T-Lymphocytes - physiology Vaccines Vaccines, DNA - administration & dosage Vaccines, DNA - adverse effects Vaccines, DNA - immunology Viral Infections Viral Vaccines - immunology Zika virus Zika Virus - immunology Zika Virus Infection - immunology Zika Virus Infection - prevention & control α-Interferon β-Interferon
ISSN:	0028-4793, 1533-4406, 1533-4406
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!